From: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study
Response
# of Patients (%) (n = 90 evaluable)
95% C. I.
Complete
10 (11%)
5.5 – 19.5
Partial
18 (20%)
12.3 – 29.8
Complete/Partial
28 (31%)
21.8 – 41.7
Stable Disease
33 (37%)
26.8 – 47.5
Progressive Disease
29 (32%)
22.8 – 42.9